AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36207156 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua Maris Extra Strong irrigation therapy in addition to standard therapy
Number of subjects: 100
Study 36207156 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 100
Study 36207156 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua Maris Extra Strong irrigation therapy
Number of subjects: 100
Study 33761717 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined music therapy + Tai Chi
Number of subjects: 0
Study 33761717 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy alone
Number of subjects: 0
Study 33761717 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi alone
Number of subjects: 0
Study 32383801 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (medication reconciliation at discharge with a link to the community pharmacist)
Number of subjects: 1092
Study 32383801 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1092
Study 36087064 — intervention group
Group type: EXPERIMENTAL
Intervention: Online compassionate imagery intervention for 2 weeks
Number of subjects: 128
Study 34772399 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of erythropoietin (EPO) 4000 IU/ml for 2 minutes before graft placement
Number of subjects: 17
Study 34772399 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of erythropoietin (EPO) 4000 IU/ml
Number of subjects: 17
Study 34772399 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control) for 2 minutes before graft placement
Number of subjects: 17
Study 35762363 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 32
Study 35762363 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Dentin Replacement (SDR)
Number of subjects: 32
Study 35762363 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic inlays
Number of subjects: 32
Study 35762363 — intervention group
Group type: COMPARATOR
Intervention: Control group (intact teeth)
Number of subjects: 32
Study 34600629 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (subsymptom threshold), at least 20 min daily for up to 4 weeks
Number of subjects: 118
Study 34600629 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise (placebo-like), at least 20 min daily for up to 4 weeks
Number of subjects: 118
Study 34020972 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 0
Study 34020972 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological interventions
Number of subjects: 0
Study 34034229 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural gliding mobilization (40 repetitions)
Number of subjects: 52
Study 34034229 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural gliding mobilization (80 repetitions)
Number of subjects: 52
Study 34214220 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional radiofrequency microneedling + PRP (group A)
Number of subjects: 20
Study 34214220 — intervention group
Group type: COMPARATOR
Intervention: Fractional radiofrequency microneedling monotherapy (group B)
Number of subjects: 20
Study 34214220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 20
Study 33913638 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3923
Study 33913638 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 3923
Study 33221326 — intervention group
Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 8 weeks (abicipar Q8, n=630)
Number of subjects: 1888
Study 33221326 — intervention group
Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 12 weeks (abicipar Q12, n=628)
Number of subjects: 1888
Study 33221326 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks (ranibizumab Q4, n=630)
Number of subjects: 1888
Study 33663225 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 15
Study 33663225 — intervention group
Group type: COMPARATOR
Intervention: Unpaced conduction
Number of subjects: 15
Study 34767866 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.03 mg
Number of subjects: 758
Study 34767866 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 0.06 mg
Number of subjects: 758
Study 34767866 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 758
Study 34767866 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01
Number of subjects: 758
Study 32598243 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravenous (i.v.) antibiotic
Number of subjects: 114
Study 32598243 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic + additional dose i.v. antibiotic
Number of subjects: 114
Study 32598243 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis + additional dose i.v. antibiotic + oral antibiotic
Number of subjects: 114
Study 34581196 — intervention group
Group type: EXPERIMENTAL
Intervention: PASTA (Posterior Arthroscopic Subtalar Arthrodesis)
Number of subjects: 56
Study 34581196 — intervention group
Group type: COMPARATOR
Intervention: Open subtalar arthrodesis
Number of subjects: 56
Study 32928003 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 1596
Study 32928003 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 1596
Study 36173619 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative body radiotherapy (SABR) to up to 5 metastases
Number of subjects: 381
Study 33539750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy
Number of subjects: 0
Study 33539750 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of pertuzumab and trastuzumab
Number of subjects: 0
Study 32602170 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination nicotine replacement therapy (cNRT)
Number of subjects: 1024
Study 32602170 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1024
Study 32602170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1024
Study 35045735 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 sessions of weekly, individualized, lifestyle education (diet and PA) with behavior change and social support delivered predominantly by telehealth.
Number of subjects: 22
Study 35045735 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone.
Number of subjects: 22
Study 33284503 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartWare or HeartMate III device
Number of subjects: 3434
Study 35964671 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme cold weather (defined by cold day and cold wave definitions)
Number of subjects: 92119
Study 35964671 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme cold weather (cold wave definitions)
Number of subjects: 92119
Study 35964671 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme cold weather impact on women
Number of subjects: 92119
Study 32869593 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μL bloodletting at tip of ear
Number of subjects: 108
Study 32869593 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μL bloodletting at tip of ear
Number of subjects: 108
Study 32869593 — intervention group
Group type: COMPARATOR
Intervention: Western medication (levofloxacin eye drops and gel)
Number of subjects: 108
Study 36080897 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% vibrotactile feedback
Number of subjects: 12
Study 36080897 — intervention group
Group type: EXPERIMENTAL
Intervention: 33% vibrotactile feedback
Number of subjects: 12
Study 36080897 — intervention group
Group type: COMPARATOR
Intervention: Unrelated vibrotactile feedback (sham condition)
Number of subjects: 12
Study 33616545 — intervention group
Group type: EXPERIMENTAL
Intervention: MAT + A-CHESS
Number of subjects: 416
Study 33616545 — intervention group
Group type: COMPARATOR
Intervention: MAT alone (control arm)
Number of subjects: 416
Study 32881906 — intervention group
Group type: EXPERIMENTAL
Intervention: Young drivers (19-25 years)
Number of subjects: 1764
Study 32881906 — intervention group
Group type: EXPERIMENTAL
Intervention: Old drivers (≥ 60 years)
Number of subjects: 1764
Study 32881906 — intervention group
Group type: COMPARATOR
Intervention: Middle-aged drivers (26-59 years)
Number of subjects: 1764
Study 36419153 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week cardiovascular rehabilitation (CVR) program
Number of subjects: 140
Study 36419153 — intervention group
Group type: COMPARATOR
Intervention: usual care 6-month wait-list control group
Number of subjects: 140
Study 34739194 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat (oral HIF-PHI)
Number of subjects: 2964
Study 34739194 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa (for hemodialysis) or darbepoetin alfa (for peritoneal dialysis) (injectable ESA)
Number of subjects: 2964
Study 34739194 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 2964
Study 34739194 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa or darbepoetin alfa
Number of subjects: 2964
Study 34657223 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnPc(Lys)5 (group B)
Number of subjects: 12
Study 34657223 — intervention group
Group type: COMPARATOR
Intervention: Hydrogen peroxide (group C)
Number of subjects: 12
Study 34657223 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (group A)
Number of subjects: 12
Study 33639993 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient instructors (SPIs) intervention with 3 visits over 3–6 months
Number of subjects: 55
Study 33639993 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 55
Study 33639993 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient instructors (SPIs) intervention
Number of subjects: 55
Study 32520654 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized active aging counseling intervention
Number of subjects: 204
Study 32520654 — intervention group
Group type: COMPARATOR
Intervention: Control group (general health information)
Number of subjects: 204
Study 35688056 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 89
Study 35688056 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 89
Study 33040811 — intervention group
Group type: EXPERIMENTAL
Intervention: Invisible orthodontic appliance with minocycline
Number of subjects: 180
Study 33040811 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐ligation orthodontic appliance with minocycline
Number of subjects: 180
Study 33040811 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional ligation bracket with minocycline
Number of subjects: 180
Study 33040811 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups with minocycline
Number of subjects: 180
Study 33040811 — intervention group
Group type: EXPERIMENTAL
Intervention: All three orthodontic treatments
Number of subjects: 180
Study 36201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (1-2 mg, oral)
Number of subjects: 28
Study 36201240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 36201240 — intervention group
Group type: COMPARATOR
Intervention: Nabilone and Placebo
Number of subjects: 28
Study 36201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone
Number of subjects: 28
Study 32212742 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific prompts
Number of subjects: 315
Study 32212742 — intervention group
Group type: COMPARATOR
Intervention: General prompts
Number of subjects: 315
Study 35501744 — intervention group
Group type: EXPERIMENTAL
Intervention: MDRT + 6 months ADT
Number of subjects: 280
Study 35501744 — intervention group
Group type: COMPARATOR
Intervention: MDRT alone
Number of subjects: 280
Study 33730016 — intervention group
Group type: EXPERIMENTAL
Intervention: Kisumu hematology reference ranges
Number of subjects: 1509
Study 33730016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in hematological values
Number of subjects: 1509
Study 33730016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences across all age groups
Number of subjects: 1509
Study 36401488 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercise program using respiratory resistance (SER)
Number of subjects: 48
Study 36401488 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercise program using respiratory resistance and whole body vibration (SERW)
Number of subjects: 48
Study 36401488 — intervention group
Group type: COMPARATOR
Intervention: Stabilization exercise (SE)
Number of subjects: 48
Study 33727311 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalation of therapy in 94 patients
Number of subjects: 1903
Study 33727311 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1903
Study 36175997 — intervention group
Group type: EXPERIMENTAL
Intervention: green‐MED diet (100 g frozen cubes/day of Wolffia globosa, 3-4 cups/day of green tea, 28 g/day of walnuts)
Number of subjects: 294
Study 36175997 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet (28 g/day of walnuts)
Number of subjects: 294
Study 36175997 — intervention group
Group type: COMPARATOR
Intervention: healthy dietary guidelines (HDG)
Number of subjects: 294
Study 33389797 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg BID)
Number of subjects: 15
Study 33389797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32228720 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal TCM treatment for mild-to-moderate plaque psoriasis
Number of subjects: 378
Study 32228720 — intervention group
Group type: COMPARATOR
Intervention: External TCM treatment for mild-to-moderate plaque psoriasis
Number of subjects: 378
Study 32228720 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM treatment for severe plaque psoriasis
Number of subjects: 378
Study 32228720 — intervention group
Group type: EXPERIMENTAL
Intervention: WM treatment for severe plaque psoriasis
Number of subjects: 378
Study 32228720 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM + WM treatment for severe plaque psoriasis
Number of subjects: 378
Study 32228720 — intervention group
Group type: COMPARATOR
Intervention: All groups (TCM, WM, TCM + WM)
Number of subjects: 378
Study 36412412 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 mcg given 3 hours prior to the procedure
Number of subjects: 36
Study 36412412 — intervention group
Group type: COMPARATOR
Intervention: No misoprostol (control group)
Number of subjects: 36
Study 32178337 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min High-Intensity Intermittent Exercise (HIIE)
Number of subjects: 39
Study 32178337 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-min High-Intensity Intermittent Exercise (HIIE)
Number of subjects: 39
Study 32178337 — intervention group
Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 39
Study 35225112 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic lumbar puncture (LP)
Number of subjects: 116
Study 35225112 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar drainage (LD)
Number of subjects: 116
Study 32391881 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive oral cannabidiol
Number of subjects: 0
Study 32391881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35264510 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal brushing and standard oral/denture hygiene
Number of subjects: 77
Study 35264510 — intervention group
Group type: COMPARATOR
Intervention: Standard oral/denture hygiene instructions only
Number of subjects: 77
Study 32964717 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (0.2 to 0.5 mg/kg as a continuous intravenous infusion for 24 hours postoperatively)
Number of subjects: 230
Study 32964717 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard hydration regimen)
Number of subjects: 230
Study 32964717 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide combined with standard hydration therapy
Number of subjects: 230
Study 32962709 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001 400, 800, 1200 or 1600 μg twice daily (BID)
Number of subjects: 1130
Study 32962709 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001
Number of subjects: 1130
Study 32962709 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001 800 and 1600 μg BID
Number of subjects: 1130
Study 32962709 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 1130
Study 32962709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study 36036525 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 4531
Study 36036525 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonist
Number of subjects: 4531
Study 34936167 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporized cannabis containing 13.75 mg THC
Number of subjects: 40
Study 34936167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33309920 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-navigated 3D whole-heart MRA
Number of subjects: 20
Study 33309920 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced CTA
Number of subjects: 20
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist support
Number of subjects: 244
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication education and management
Number of subjects: 244
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐medication‐related patient education
Number of subjects: 244
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 244
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination
Number of subjects: 244
Study 32115392 — intervention group
Group type: EXPERIMENTAL
Intervention: Miscommunication related to scheduling
Number of subjects: 244
Study 35248290 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal mobilisation intervention
Number of subjects: 40
Study 35248290 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 40
Study 33459183 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive design integrating dose finding and confirmation steps
Number of subjects: 0
Study 33459183 — intervention group
Group type: EXPERIMENTAL
Intervention: Response adaptive randomization, sample size modification, and multiple testing techniques
Number of subjects: 0
Study 33761716 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-induction warming using a forced-air warmer set at 47°C
Number of subjects: 130
Study 33761716 — intervention group
Group type: COMPARATOR
Intervention: Control group covered passively with a cotton blanket
Number of subjects: 130
Study 33761716 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-induction warming
Number of subjects: 130
Study 33761716 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study 33761716 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-induction warming and Control group
Number of subjects: 130
Study 36152053 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful electrical shock paired with words
Number of subjects: 25
Study 36152053 — intervention group
Group type: COMPARATOR
Intervention: Non-pain associated words
Number of subjects: 25
Study 32712388 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant side CVAD insertion
Number of subjects: 640
Study 32712388 — intervention group
Group type: COMPARATOR
Intervention: Non-dominant side CVAD insertion
Number of subjects: 640
Study 35790981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fee-for-service (FFS)
Number of subjects: 210
Study 35790981 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis-Related Group (DRG)
Number of subjects: 210
Study 35790981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed payment schemes (including two FFS-based and three DRG-based)
Number of subjects: 210
Study 35790981 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher disease severity
Number of subjects: 210
Study 35790981 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower disease severity
Number of subjects: 210
Study 33928908 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini yoga
Number of subjects: 40
Study 33928908 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene
Number of subjects: 40
Study 35038027 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic modified cartilage over‐underlay myringoplasty with packing (n=35)
Number of subjects: 70
Study 35038027 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic modified cartilage over‐underlay myringoplasty without packing (n=35)
Number of subjects: 70
Study 34559230 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of FRM-0334
Number of subjects: 27
Study 34559230 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of FRM-0334
Number of subjects: 27
Study 34559230 — intervention group
Group type: EXPERIMENTAL
Intervention: FRM-0334 (both doses)
Number of subjects: 27
Study 34559230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 34559230 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifrontal FDG-PET
Number of subjects: 27
Study 34985771 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention supporting couples' posttreatment recovery of sexual intimacy, comprising 6 modules addressing expectations for sexual and emotional sequelae of treatment, rehabilitation, and guidance toward sexual intimacy recovery.
Number of subjects: 142
Study 34985771 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention supporting couples' posttreatment recovery of sexual intimacy.
Number of subjects: 142
Study 34985771 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 142
Study 32783330 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical PR gel under the left orbit once a day and topical plus nano‐microneedle‐assisted PR gel under the right orbit twice a week
Number of subjects: 20
Study 32783330 — intervention group
Group type: COMPARATOR
Intervention: Gel without PR (Control)
Number of subjects: 20
Study 34427049 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP5354 0.1 mg
Number of subjects: 6